Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Metastatic Castration-resistant Prostate Cancer × Bortezomib × 90 days × Clear all

Sponsor

Conditions

Multiple Myeloma 49 Neoplasms, Plasma Cell 5 Immunoglobulin Light-chain Amyloidosis 5 Recurrence 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Paraproteinemias 3 Waldenstrom Macroglobulinemia 2 Renal Insufficiency 2 Neoplasms 2 Lymphoproliferative Disorders 2 Leukemia, Myeloid, Acute 2 Burkitt Lymphoma 2 Amyloidosis 2 beta-Thalassemia 1 Triple Negative Breast Neoplasms 1 Thalassemia 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasm, Residual 1 Myelodysplastic Syndromes 1 Multi-centric Castleman's Disease 1 Macular dystrophy, corneal type 1 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Lymphadenopathy 1 Immunoproliferative Disorders 1 Hematologic Neoplasms 1 HIV Infections 1 Breast Neoplasms 1 Anemia, Sickle Cell 1

Interventions

olaparib 2 Pluvicto 2 testosterone 17 beta-cypionate 1 sarilumab 1 radium Ra 223 dichloride 1 lactitol 1 fludarabine phosphate 1 fludarabine 1 enzalutamide 1 enfortumab vedotin 1 darolutamide 1 cemiplimab 1 Radium-223 1 Prednisone 1 Prednisolone 1 PSMA-617 1 Nivolumab 1 Gonadotropin-Releasing Hormone 1 Docetaxel 1 Cyclophosphamide 1 Blood Specimen Collection 1 Androgen Antagonists 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡